Status:
UNKNOWN
Effect of Consuming Products Containing Rare Sugars Alongside Sucrose on Glycaemic Response in Healthy Adults
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
Nottingham University Hospitals NHS Trust
Conditions:
Glycaemic Response in Healthy Participants
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Food manufacturers are being tasked to reduce the added sugar content of products. Rare, but natural sugars, may serve as useful sweeteners as they are low-calorie, safe, sweet and have a mild taste. ...
Detailed Description
Main Hypotheses: This study is designed to test two main hypotheses: 1. Sweet crème products containing the rare sugars arabinose or tagatose will cause a lower spike in blood glucose and insulin th...
Eligibility Criteria
Inclusion
- Healthy adults of any gender and any sociodemographic background, who are capable of giving informed consent.
- Aged 18 years or over (no upper age limit).
- Able to understand spoken and written English well enough to understand the consent forms and information sheets, and to give responses to questionnaires.
Exclusion
- Diagnosed hyperglycaemia, insulin resistance, diabetes or high blood pressure.
- Allergy, intolerance, sensitivity or dietary restriction that would prevent the consumption of the sweet crème samples.
- Anxiety/phobias that would prevent the sampling of venous blood.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05353712
Start Date
May 1 2022
End Date
November 1 2022
Last Update
April 29 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nottingham
Loughborough, Leicestershire, United Kingdom, LE12 5RD
2
Clinical Research Facility, Medical School, University of Nottingham
Nottingham, Nottinghamshire, United Kingdom, NG7 2UH